Gestational age at initiation of 17-alpha hydroxyprogesterone caproate and recurrent preterm birth

Add time:07/16/2019    Source:sciencedirect.com

BackgroundPreterm birth is the leading cause of neonatal morbidity and mortality in nonanomalous neonates in the United States. Women with a previous early spontaneous preterm birth are at highest risk for recurrence. Weekly intramuscular 17-alpha hydroxyprogesterone caproate reduces the risk of recurrent prematurity. Although current guidelines recommend 17-alpha hydroxyprogesterone caproate initiation between 16 and 20 weeks, in clinical practice, 17-alpha hydroxyprogesterone caproate is started across a spectrum of gestational ages.

We also recommend Trading Suppliers and Manufacturers of 14-Hydroxyprogesterone (cas 16031-66-6). Pls Click Website Link as below: cas 16031-66-6 suppliers

Prev:Characterization of the hydrophobic interaction of steroids with endoplasmic reticulum membranes by quenching of 6,8(14)-bisdehydro-17α-hydroxyprogesterone fluorescence
Next:Sulfonamide hybrid schiff bases of anthranilic acid: Synthesis, characterization and their biological potential)